Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model.

MLA

Rosadas, Carolina, et al. “Economic Analysis of Antenatal Screening for Human T-Cell Lymphotropic Virus Type 1 in Brazil: An Open Access Cost-Utility Model.” The Lancet. Global Health, vol. 11, no. 5, May 2023, pp. e781–90. EBSCOhost, https://doi.org/10.1016/S2214-109X(23)00065-7.

APA

Rosadas, C., Senna, K., da Costa, M., Assone, T., Casseb, J., Nukui, Y., Cook, L., Mariano, L., Galvão Castro, B., Rios Grassi, M. F., Penalva de Oliveira, A. C., Caterino-de-Araujo, A., Malik, B., Boa-Sorte, N., Peixoto, P., Puccioni-Sohler, M., Santos, M., & Taylor, G. P. (2023). Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model. The Lancet. Global Health, 11(5), e781–e790. https://doi.org/10.1016/S2214-109X(23)00065-7

Chicago

Rosadas, Carolina, Kátia Senna, Milene da Costa, Tatiane Assone, Jorge Casseb, Youko Nukui, Lucy Cook, et al. 2023. “Economic Analysis of Antenatal Screening for Human T-Cell Lymphotropic Virus Type 1 in Brazil: An Open Access Cost-Utility Model.” The Lancet. Global Health 11 (5): e781–90. doi:10.1016/S2214-109X(23)00065-7.